Maryann Mikucki, MD, PhD Maryann Mikucki, MD, PhD

Maryann Mikucki


About Maryann Mikucki


Expected Graduation: 2021


Roswell Park Comprehensive Cancer Center
  • Radiation Medicine Resident


Education and Training:

  • Internship - University at Buffalo, Internal Medicine Transitional Year, Buffalo, NY
  • MD - University at Buffalo, Jacobs School of Medicine, Buffalo, NY
  • Undergraduate - University of Rochester, Rochester, NY


  • Mikucki ME, Skitzki JJ, Frelinger JG, Odunsi K, Gajewski TF, Luster AD, Evans SS.  Unlocking tumor vascular barriers with CXCR3: Implications for cancer immunotherapy.  OncoImmunology. 2016 Feb 11;5(5): e1116675.
  • Mikucki ME, Fisher DT, Matsuzaki J, Skitzki JJ, Gaulin NB, Muhitch JB, Ku AW, Frelinger JG, Odunsi K, Gajewski TF, Luster AD, Evans SS.  Non-redundant requirement for CXCR3 signaling during tumoricidal T-cell trafficking across tumour vascular checkpoints.  Nature Communications. 2015 Jun 25;6:7458.
  • Mikucki ME, Fisher DT, Ku AW, Appenheimer MM, Muhitch JB, Evans SS.  Preconditioning thermal therapy: Flipping the switch on IL-6 for anti-tumour immunity.  Int J Hyperthermia. 2013 Aug; 29(5):464-73.
  • Quartley E, Alexandrov A, Mikucki ME, Buckner FS, Hol WG, DeTitta GT, Phizicky EM, and Grayhack EJ. Heterologous expression of L. major proteins in S. cerevisiae: a test of solubility, purity, and gene recoding. J Struct Funct Genomics 2009, Sep 10(3):233-47.